Posts by Sandra Ansanay-Alex
OneDoc Merges With Medicosearch
OneDoc, the leading Swiss platform for booking online medical appointments, has acquired Medicosearch. This transaction is another important step in the development of the Geneva-based company, consolidating its position as the leading player in digital healthcare in Switzerland, with over 13,000 registered healthcare professionals and more than 350,000 consultations booked online each month. The new…
Read MoreDePoly raised $23 Million
The Valais-based scale-up and HES-SO Valais-Wallis spinoff prepares to demonstrate industrial-scale implementation of its revolutionary technology that transforms plastic waste into virgin-quality raw materials without fossil fuels. Every year, millions of tons of PET and polyester waste end up in landfills or are incinerated, yet sustainable recycling solutions remain limited. DePoly – the leading…
Read MoreNestlé Opens A New R&D Centre Dedicated To Biotech And Deeptech In Orbe
Nestlé announced the strengthening of its R&D expertise in biotechnology and the creation of a new centre for deep tech, to boost its innovation pipeline and increase efficiency in research, innovation and operations. The investments will be unlocked by a leaner R&D organization, more agile ways of working, a focused project portfolio and the redeployment of existing R&D…
Read MoreAnnaida Technologies SA closes oversubscribed Pre-Series A
Annaida Technologies, a Vaud-based start-up company bringing magnetic resonance to the scale of cells, announces the successful closing of its oversubscribed Pre-Series A funding round. The round, led by HEMEX, saw the participation from existing investors including Zürcher Kantonalbank (ZKB), Excellis, EFI Lake Geneva Ventures, and members of Club degli Investitori through Simon…
Read MoreAdoram Therapeutics Secures CHF 1 Million Grant from Innosuisse
Adoram Therapeutics has secured a CHF 1.05 million grant from Innosuisse to propel its groundbreaking anti-inflammatory programme, aiming to develop safer and more effective therapies. Adoram Therapeutics is a University of Geneva (UNIGE) spinoff specializing in allosteric modulators for cancer immunotherapy and inflammatory conditions. The Innosuisse Grant will allow the research will be…
Read More4 Swiss Start-Ups join Tech4Eva
Tech4Eva, Switzerland’s first start-up acceleration programme dedicated to women’s health (FemTech), has kicked off its fifth edition with a record-breaking 195 applications from 42 countries. Among the 16 start-ups selected for this year’s 6-month program, four promising companies hail from Switzerland—further underscoring the country’s growing role in this dynamic sector. This year’s Swiss cohort includes:…
Read MoreDigeHealth supported by FIT
DigeHealth is an EPFL Spinoff detecting post-operative complications using a device to analyse intestinal sounds and just received a CHF 100,000 Tech Seed loan from FIT, Fondation pour l’Innovation Technologique. In the post-operative period, a significant proportion of patients experience intestinal complications, such as post-operative ileus or intestinal obstruction. If not detected in time,…
Read MoreH4: A Pragmatic Hub for Health and Care Innovation
In a world where the challenges of the health and care sectors are multiplying, H4 positions itself as a unique innovation hub in Lausanne, Switzerland. Through its pragmatic and collaborative approach, H4 supports groundbreaking projects and accelerates the development of impactful and sustainable solutions. Since its creation in 2022, with the support of the Fondation…
Read MoreHAYA Therapeutics Raises $65 Million in Series A Funding
The Series A round is led by Sofinnova Partners and Earlybird Venture Capital with syndicate including Eli Lilly and Company. The funding will help advance clinical development of heart failure lead candidate and expand platform targeting the regulatory genome. HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram…
Read MoreCarewell Wins the 2025 PERL Trophy
The 23rd edition of the Prix Entreprendre Lausanne Région (PERL) took place on Wednesday 7 May, at Beaulieu-Lausanne, gathering around 300 leaders from politics, business, and academia. The prestigious Lausanne Région Trophy, worth CHF 50,000, was awarded to Carewell, a company based in Pully, for its innovative project at the intersection of technology and social…
Read More